- Horizon (NASDAQ:HZNP) presents at the JPMorgan Healthcare conference at 10:30 ET.
- The presentation will include a financial update, and the company estimates year-end cash on hand of $500M and debt of $1.945B.
- Full-year 2016 sales from Pennsaid, Duexis, and Vimovo are expected at roughly $600M.
- Shares +2.4%
- #JPM17
Horizon Pharma +2.4% ahead of conference presentation
Recommended For You
More Trending News
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
HZNP | - | - |
Horizon Therapeutics Public Limited Company |